The Gut–Skin Axis and Rosacea

Written By Joey .

Rosacea is one of those conditions that patients are told to simply "manage" — a rotation of topical creams and trigger avoidance that rarely produces lasting remission. In my clinical experience, and increasingly in the research literature, the reason conventional treatment so often disappoints is that it addresses the surface while leaving the systemic terrain untouched. Rosacea and the gut–skin axis are deeply intertwined — and understanding that connection fundamentally changes how we approach both investigation and treatment.

This post brings together the evidence on rosacea's gut–skin axis, the role of Demodex overgrowth, SIBO and intestinal permeability, dietary triggers including nightshades, and a frank comparison of conventional versus botanical treatment approaches — including where azelaic acid fits into the picture.

◆ Quick Answer

What is the connection between rosacea and the gut? Rosacea is significantly associated with gut dysbiosis — particularly SIBO, Helicobacter pylori infection, inflammatory bowel disease, and increased intestinal permeability. The gut–skin axis mechanism proposes that dysbiosis increases gut permeability, allowing pro-inflammatory bacterial components and cytokines into systemic circulation — triggering chronic facial inflammation. In a pivotal clinical study, eradicating SIBO produced complete or near-complete rosacea clearance in over 78% of patients, maintained for at least 9 months.1,2

Rosacea Is Not Just a Skin Problem

Rosacea is a chronic, relapsing inflammatory condition characterised by persistent central facial erythema, flushing, telangiectasia, papules, and pustules — but its pathophysiology extends far beyond the skin. A growing body of evidence has established significant associations between rosacea and a range of systemic and gastrointestinal conditions: inflammatory bowel disease, celiac disease, irritable bowel syndrome, gastroesophageal reflux disease, Helicobacter pylori infection, and SIBO.2,3

Rosacea patients also show meaningfully elevated rates of cardiovascular risk factors — including dyslipidaemia, insulin resistance, and hypertension — with one cross-sectional study finding metabolic syndrome criteria met in 44% of rosacea patients compared with 35% of controls, alongside significantly higher inflammatory markers.4 This is not coincidence. It reflects a systemic inflammatory burden that drives rosacea from the inside out.

The question that should drive clinical management is not "which topical should we apply?" but "what internal disruption is creating the conditions for this chronic facial inflammation?"

The Gut–Skin Axis and Rosacea: What the Research Shows

The gut–skin axis is the bidirectional communication network between intestinal microbiota, the immune system, and skin physiology. In rosacea, the evidence for this connection is striking — and perhaps most compelling when it comes to SIBO.

SIBO: The Most Clinically Actionable Gut Connection

📄 Landmark Research — Parodi et al., Clin Gastroenterol Hepatol (2008)

In 113 consecutive rosacea patients, the prevalence of SIBO was 46% compared to just 5% in healthy controls — making rosacea patients approximately 13 times more likely to have SIBO. In the randomised treatment arm, after rifaximin eradication of SIBO, cutaneous lesions completely cleared in 71% and greatly improved in a further 21% of patients, maintained for at least 9 months. Placebo patients remained unchanged or worsened.1

📄 3-Year Follow-Up — Drago et al., J Am Acad Dermatol (2016)

The 3-year follow-up of the Parodi cohort confirmed that successful SIBO eradication was critical for sustained remission. Rosacea recurrence correlated with SIBO recurrence — providing a compelling mechanistic link rather than coincidence.5

The mechanism is plausible and increasingly characterised: SIBO increases intestinal permeability, allowing bacterial components, endotoxins, and pro-inflammatory cytokines (notably TNF-α) to enter systemic circulation, triggering the innate immune dysregulation and neurovascular inflammation characteristic of rosacea.2,3 This is the gut–skin axis in action.

13× Rosacea patients are approximately 13 times more likely to have SIBO than healthy controls. Treating SIBO alone produced complete or near-complete rosacea clearance in over 78% of treated patients.1

Helicobacter pylori

The association between rosacea and H. pylori infection is among the most consistently reported in the literature — and the strongest single gastrointestinal association overall.2 H. pylori triggers rosacea through multiple mechanisms: direct stimulation of pro-inflammatory cytokines, induction of reactive oxygen species, and upregulation of mast cell activity and kallikrein-5 — a key mediator of rosacea inflammation. Multiple studies have reported improvement in rosacea following H. pylori eradication.2,3

Intestinal Permeability: The Unifying Mechanism

Underpinning many gut–rosacea associations is altered intestinal barrier function — "leaky gut." When tight junctions between intestinal epithelial cells are compromised, microbial metabolites, lipopolysaccharides, and undigested food antigens translocate into the bloodstream, triggering systemic immune activation.3,6

This mechanism helps explain why the gut–skin axis in rosacea is broader than any single organism. Post-antibiotic microbiome disruption, SIBO, H. pylori, inflammatory bowel disease, and chronic stress all converge on the same pathway: disrupted gut barrier → systemic translocation of inflammatory signals → amplified facial vascular and immune reactivity.

It is also why I always ask rosacea patients about their antibiotic history. Repeated broad-spectrum antibiotic courses — particularly in the years preceding rosacea onset — is among the most common clinical patterns I observe. Antibiotics reduce the microbial diversity that maintains gut barrier integrity, creating the conditions for dysbiosis and subsequent permeability.6

Dietary Triggers and Rosacea: The Nightshade Question

Diet is one of the most consistently reported but mechanistically under-explained aspects of rosacea management. The established triggers — alcohol, hot beverages, spicy foods, histamine-rich foods — have reasonably clear mechanisms via transient receptor potential (TRP) cation channel activation, which drives neurogenic vasodilation.7

Nightshades (tomatoes, peppers, aubergine, potatoes) are less consistently reported in the literature but are a recurring clinical observation. Their relevance may come from several angles:

  • Alkaloids: Nightshades contain solanine and other alkaloids that can increase intestinal permeability in susceptible individuals — directly feeding the gut–skin axis mechanism.
  • Histamine liberation: Tomatoes are potent histamine liberators, capable of degranulating mast cells and amplifying the vascular reactivity underlying rosacea flushing.
  • Capsaicin: Acts on TRPV1 receptors in both the gut and skin, capable of triggering neurogenic inflammation through substance P release.7

The response to nightshade restriction is highly individual. For patients with confirmed intestinal hyperpermeability or known sensitivity patterns, a structured 4–6 week elimination trial is reasonable — but I don't recommend universal nightshade removal without clinical indication.

AlcoholVasodilation, histamine, microbiome disruption
Hot beveragesThermal TRPV1 activation → flushing
Spicy / capsaicinTRPV1 → neurogenic vasodilation, gut permeability
NightshadesAlkaloids, histamine liberation, gut permeability
AntibioticsMicrobiome disruption → dysbiosis → gut–skin axis
Stress / cortisolImmune suppression, mast cell activation
UV / heat exposureKallikrein-5, cathelicidin overexpression
Undiagnosed allergiesIgE-mediated mast cell activation amplifying baseline reactivity

Demodex Overgrowth: The Commensal That Became Pathogenic

Demodex folliculorum and Demodex brevis are microscopic mites that normally inhabit human pilosebaceous units — everyone has them. In rosacea patients, particularly papulopustular subtype, Demodex density is significantly elevated compared with healthy controls, and the relationship between high density and rosacea severity is well-documented.8,9

Like Malassezia in seborrheic dermatitis, the clinical question is not simply "does Demodex cause rosacea?" but "what disrupts the terrain sufficiently to allow Demodex to proliferate pathogenically?" The mites' Gram-negative bacterial endosymbiont Bacillus oleronius has been shown to stimulate immune responses in rosacea patients, and their physical presence disrupts follicular architecture and barrier function.8

Conventional Treatment: Ivermectin

Topical ivermectin 1% cream is the standard pharmaceutical intervention for Demodex-associated papulopustular rosacea. A systematic review by Ebbelaar et al. (2018) confirmed it is more effective than metronidazole at 12 weeks (NNT = 10.5), with both anti-inflammatory and acaricidal properties.9

However, the same review identified a critical limitation: approximately two-thirds of patients relapse within 36 weeks of discontinuing treatment — 62.7% for ivermectin and 68.4% for metronidazole. This relapse pattern reflects the fundamental problem with surface-only treatment: the terrain enabling the overgrowth remains unchanged. There is also a reported case of ivermectin-resistant Demodex, raising the possibility of emerging resistance with chronic use.10

Note: Ivermectin cream targets only the protozoan Demodex. It has no meaningful activity against bacteria, fungi, or viruses — meaning it does not address the broader microbial terrain disruption contributing to rosacea. Relapse risk exceeds 60% within 9 months of stopping.9

Botanical Alternatives: Tea Tree Oil, Lemongrass, and Clove vs. Ivermectin

The in vitro data on certain essential oils compared with ivermectin tells a clinically interesting story about mechanism, speed, and spectrum of activity.

📄 Paichitrojjana et al., Clin Cosmet Investig Dermatol (2023)

This study directly compared 11 Thai herbal essential oils, tea tree oil, and metronidazole 0.75% against Demodex folliculorum in vitro, using ivermectin 1% as the positive control. All herbal essential oils killed Demodex within 16 minutes. The efficacy ranking was: lemongrass oil > sweet basil > clove oil > tea tree oil > ivermectin 1% > metronidazole. Lemongrass, sweet basil, and clove killed mites within 4 minutes — dramatically faster than ivermectin. Mites exposed to essential oils shrank and deformed within minutes, while ivermectin-exposed mites took 2 hours to show comparable effects.11

📄 Yurekli, J Cosmet Dermatol (2022)

Tea tree oil at 2.5%–100% demonstrated dose-dependent in vitro killing activity against Demodex folliculorum, with 100% TTO producing a mean survival time of 3.3 minutes. All TTO concentrations significantly outperformed permethrin 5%.12

Property Ivermectin 1% Metronidazole Tea Tree / Lemongrass / Clove
Anti-Demodex (acaricidal) Yes Weak Yes — faster in vitro
Antibacterial No Yes (limited spectrum) Yes (broad spectrum)
Antifungal No No Yes
Antiviral No No Yes (TTO especially)
Resistance risk Case report documented10 Increasing resistance No known resistance mechanism
Relapse rate after stopping ~63% at 36 weeks9 ~68% at 36 weeks9 In vitro only; in vivo data limited
Skin microbiome impact Disrupts microbiome Disrupts skin and gut microbiome Preserved at appropriate dilution

Tea tree oil's active component terpinen-4-ol (T4O) carries anti-parasitic, antibacterial, antifungal, antiviral, and anti-inflammatory properties — a spectrum ivermectin (exclusively acaricidal and anti-inflammatory) does not match.10 The practical caveat is dilution: TTO above 5% can cause irritation and should always be used in an appropriate carrier. Lemongrass and clove oils similarly require dilution. For patients with chronic relapsing Demodex-associated rosacea where pharmaceutical dependence carries escalating risks, these represent a biologically rational, resistance-free alternative worth discussing.

Azelaic Acid in Rosacea: A Dual-Mechanism Intervention

Azelaic acid holds a well-evidenced place in rosacea management — it is both anti-inflammatory and has direct activity against the microbial environment associated with Demodex, and also helps with post-inflammatory erythema and pigmentation.13 It works through inhibition of kallikrein-5 (which drives cathelicidin overexpression — a central mediator of rosacea inflammation), alongside prostaglandin and cytokine inhibition, and mild antimicrobial effects.

As a topical, azelaic acid is generally well-tolerated but can cause stinging in patients with significantly compromised barrier function — the very patients who often need it most. This is where formulation, concentration, and application technique matter considerably.

✦ Azelaic Acid Chemical Peel — In-Clinic Service

For cases where topical cream concentrations aren't achieving sufficient results, we offer an in-clinic azelaic acid peel — a higher-concentration treatment delivering deeper anti-inflammatory and anti-rosacea effects. Suitable for papulopustular rosacea, post-inflammatory redness, and patients where topicals have plateaued. Book a consultation to find out if you're a candidate.

One consideration I always raise with patients: azelaic acid works best when the gut and microbiome environment is also being addressed. Applying it to skin inflamed by SIBO-driven systemic inflammation is treating the symptom while the source continues uninterrupted.

Allergies, Post-Antibiotic Disruption, and the Bigger Picture

Allergies and IgE-Mediated Reactivity

IgE-mediated allergic reactions and food intolerances can amplify rosacea reactivity through mast cell degranulation — releasing histamine, prostaglandins, and vasoactive mediators that overlap directly with rosacea flushing and erythema. A patient with undiagnosed food allergies may be maintaining a background level of mast cell activation that lowers the threshold for all other rosacea triggers significantly. Basic allergy testing and a structured elimination approach can be diagnostically and therapeutically valuable in these cases.

Post-Antibiotic Microbiome Disruption

Antibiotic history is a critical piece of the rosacea puzzle. Broad-spectrum antibiotics reduce microbial diversity, disrupt the protective bacterial populations that maintain gut barrier integrity, and create the dysbiotic conditions that feed the gut–skin axis.6 The paradox — and one I raise directly with patients — is that rosacea is routinely treated with long-term oral antibiotics (doxycycline, tetracycline), which may provide short-term improvement while simultaneously perpetuating the gut dysbiosis that underlies their condition.

This is not an argument against antibiotics. It is an argument for always pairing antibiotic treatment with probiotic support — particularly Saccharomyces boulardii, as I discuss in my post on skin microbiome balance — and for investigating whether the gut is a root driver before committing to long-term antibiotic protocols.

Is Rosacea Caused by Gut Problems?

Gut dysfunction is not the sole cause of rosacea, but the evidence strongly supports it as a significant contributing and perpetuating factor in a meaningful subset of patients. Rosacea patients have significantly higher rates of SIBO, inflammatory bowel disease, H. pylori, and celiac disease than the general population.2,3 The Parodi et al. study showed that treating SIBO alone produced near-complete rosacea clearance in over 78% of SIBO-positive patients, maintained for 9 months.1 The gut–skin axis mechanism — dysbiosis → intestinal permeability → systemic cytokine activation → skin inflammation — is biologically plausible and increasingly well-evidenced. Not every rosacea patient has gut disease, but every rosacea patient deserves to be asked about their gut health.

What Is the Best Natural Treatment for Demodex in Rosacea?

Tea tree oil (terpinen-4-ol / T4O) has the strongest evidence base among natural treatments for Demodex-associated rosacea, outperforming metronidazole and matching or exceeding ivermectin in multiple in vitro studies. Used at 5% concentration in an appropriate carrier, TTO has demonstrated acaricidal, antibacterial, antifungal, antiviral, and anti-inflammatory activity — a spectrum conventional pharmaceutical acaricides do not provide.10,11 Lemongrass and clove oils also showed superior in vitro Demodex-killing speed compared to ivermectin. The critical advantage is the absence of a known resistance mechanism. These are topical approaches that address the surface; the systemic terrain — gut health, immune status, triggers — must also be addressed for sustainable remission.

Frequently Asked Questions: Rosacea and the Gut–Skin Axis

What gut conditions are most associated with rosacea?

The most consistently associated conditions are H. pylori infection (strongest evidence overall), SIBO, inflammatory bowel disease (particularly Crohn's disease), celiac disease, irritable bowel syndrome, and GERD.2,3 The link involves shared genetic predispositions, immune dysregulation, and the gut–skin axis — whereby gut dysbiosis drives systemic inflammation that manifests in skin.

Should I test for SIBO if I have rosacea?

If you have rosacea alongside gut symptoms — bloating, altered bowel habits, reflux, food intolerances — SIBO testing is clinically reasonable and potentially highly informative. The Parodi data showed ~46% of unselected rosacea patients had SIBO, and treating it produced dramatic skin improvement.1 Results should be interpreted alongside clinical context. If positive, treatment may be as important for your rosacea as any topical.

Why does my rosacea keep coming back after treatment?

Recurrence is the most telling sign that root cause hasn't been addressed. Topical treatments suppress the surface without resolving the underlying terrain: gut dysbiosis, Demodex overgrowth, systemic immune activation, dietary triggers, and hormonal factors all continue operating when treatment stops. Relapse rates with conventional topicals exceed 60% within 9 months.9 Sustainable improvement requires identifying and addressing the contributing factors unique to each patient.

Are nightshades bad for rosacea?

Nightshades are a commonly reported trigger for a subset of patients, potentially through intestinal alkaloid content, histamine liberation (particularly tomatoes), and capsaicin-mediated TRPV1 activation.7 Individual response varies considerably. A structured 4–6 week elimination trial is reasonable for patients with gut sensitivity or food intolerances whose flares seem diet-linked but lack a clear culprit.

Is tea tree oil safe on rosacea skin?

At appropriately diluted concentrations — typically 5% in a carrier — tea tree oil is generally well-tolerated with an established evidence base for reducing Demodex density.10,12 Above 5%, it can cause irritation. Given rosacea patients often have compromised barriers, patch testing before regular use is always recommended. TTO is not a replacement for investigating the gut–skin axis, but it is one of the most evidence-supported botanical options available.

A Practical Framework: Investigating Rosacea Root Causes

In my practice, rosacea consultation follows an integrative protocol rather than a purely topical one. The investigation covers:

  • Gut assessment: Detailed history of SIBO symptoms, antibiotic history, H. pylori status, bowel habits, food intolerances. SIBO breath testing where clinically indicated.
  • Demodex status: Clinical assessment of papulopustular distribution; skin scraping where density assessment is useful.
  • Trigger documentation: A structured 4–6 week diary covering diet (including nightshades, alcohol, spices, histamine-rich foods), stress, temperature, skincare, and hormonal patterns.
  • Allergy and sensitivity panel: IgE and IgG food reactivity testing where clinical history suggests allergy-driven amplification.
  • Metabolic and inflammatory markers: CRP, insulin resistance markers, thyroid function — given the association between rosacea and metabolic syndrome.4
  • Nutritional status: Vitamin D, B vitamins, zinc — as outlined in my posts on skin microbiome conditions and hormonal skin changes.
Tired of treating rosacea on repeat with no lasting results?

Book a functional skin consultation and let's investigate the full picture — gut health, triggers, microbiome, and metabolic status — to build a plan that targets the cause, not just the surface.

Further Reading & Trusted Sources

References

  1. Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6(7):759–764.
  2. Wang F-Y, Chi C-C. Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut–skin axis of rosacea. Adv Ther. 2021;38:1415–1424. doi:10.1007/s12325-021-01624-x.
  3. Sánchez-Pellicer P, et al. Rosacea, microbiome and probiotics: the gut-skin axis. Front Microbiol. 2024;14:1323644. doi:10.3389/fmicb.2023.1323644.
  4. Ozbagcivan O, Ozturk T, Akarsu S, Ilknur T, Fetil E. Evaluation of metabolic syndrome and its components in patients with rosacea: a cross-sectional, case-control study. Hong Kong J Dermatol Venereol. 2020;28:55–62.
  5. Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterial overgrowth in rosacea: a 3-year follow-up. J Am Acad Dermatol. 2016;75(3):e113–e115.
  6. Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: the relationship between intestinal bacteria and skin health. World J Dermatol. 2017;6(4):52–58.
  7. Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017;7(4):31–37. PMC5718124.
  8. Lacey N, Raghallaigh SN, Powell FC. Demodex mites — commensals, parasites or mutualistic organisms? Dermatology. 2011;222(2):128–130.
  9. Ebbelaar CCF, Venema AW, Van Dijk MR. Topical ivermectin in the treatment of papulopustular rosacea: a systematic review. Dermatol Ther (Heidelb). 2018;8:379–387. doi:10.1007/s13555-018-0249-y.
  10. Huang HP, et al. Comparison of the efficacy of tea tree oil with other pharmacological management in human demodicosis: a systematic review. Life. 2023. PMC10317738.
  11. Paichitrojjana A, et al. Comparison of in vitro killing effect of Thai herbal essential oils, tea tree oil, and metronidazole versus ivermectin on Demodex folliculorum. Clin Cosmet Investig Dermatol. 2023;16:1139–1148. doi:10.2147/CCID.S414737.
  12. Yurekli A. The comparative in vitro killing activity of tea tree oil versus permethrin on Demodex folliculorum of rosacea patients. J Cosmet Dermatol. 2022;21:2268–2272. doi:10.1111/jocd.14701.
  13. Draelos ZD, Fleischer AB, Bhalla R, et al. Azelaic acid in the treatment of rosacea. J Drugs Dermatol. 2005;4(4):475–482.
  14. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology. 1995;191(1):6–8.
  15. Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth. J Am Acad Dermatol. 2013;68(5):875–876.
Joey .